Prospective WCD Post CABG Registry (CABG Registry)

Recruiting now

Conditions studied: Cardiomyopathy Ischemic, Cardiomyopathies, Cardiovascular Diseases, Heart Disease, Ischemic

In brief

The primary objective is to observe the rate of recovery of ventricular function (EF\>35%) after first-time coronary artery bypass graft surgery in patients who were prescribed the wearable cardioverter defibrillator (WCD) post-surgery prior to being discharged after hospitalization as part of standard clinical care.

Key facts

Study ID

NCT06570902

Run by

Zoll Medical Corporation

People needed

910

Starts

2024-09-23

Expected to finish

2030-05-01

Last updated by the study team

2024-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient underwent first-time CABG surgery <10 days before enrollment.
• Patient is prescribed WCD for a primary reason of HF with reduced EF < 35% measured after surgery but before hospital discharge.
• Patient is ≥18 years old

You may not qualify if…

• Patients having combination CABG surgery with heart valve repair.
• Patients with prior CABG.
• Patients who have an active unipolar pacemaker.
• Patients with a physical or mental condition that could impair their ability to properly interact with the WCD.
• Patients currently participating in an interventional clinical study. Patients with any skin condition that would prevent wearing the device. Patients with an advanced directive prohibiting resuscitation.

Where it is running

• Medizinische Hochschule Hannover — Hanover, Lower Saxony, Germany (enrolling)
• Sana-Herzzentrum Cottbus GmbH — Cottbus, Germany (enrolling)
• Universitätsklinikum Halle (Saale) — Halle, Germany (enrolling)
• Kerckhoff Klinik — Bad Nauheim, Hesse, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.